Screening for West Nile Virus: More uncertainty

American Journal of Transplantation

Volumn 4, Issue 8, 2004, Pages 1217-1218

  Humar, Atul ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; MENINGOENCEPHALITIS; NONHUMAN; NUCLEIC ACID AMPLIFICATION; ORGAN DONOR; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RNA VIRUS; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VIREMIA; VIRUS DETECTION; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; BLOOD-BORNE PATHOGENS; HUMANS; MASS SCREENING; WEST NILE FEVER; WEST NILE VIRUS;

EID: 3543002913     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00528.x     Document Type: Review

References (5)

1. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. West Nile virus. Lancet Infect Dis 2002; 2: 519-529.
2. Pealer LN, Marfin AA, Petersen LR et al. Transmission of West Nile Virus through Blood Transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236-1245.
3. Iwamoto M, Jemigan DB, Guasch A et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348: 2196-2203.
4. Kumar D, Prasad GV, Zaltzman J, Levy GA, Humar A. Community-acquired West Nile virus infection in solid organ transplant recipients. Transplantation 2004; 77: 399-402.
5. Kiberd BA, Forward K. Screening for West Nile in organ transplantation: A medical decision analysis. Am J Transplant 2004; 4: 1296-1301.